All Type of News
Dumping war looming in hospital bidding markets
A recent tender in the local hospital market has produced negative side effects that require the attention of policymakers, including the possibility of predatory pricing, commonly referred to as “dumping.”
In Kor...
Binex , Abdi Ibrahim sign deal to sell Remicade biosimiar
Binex Pharmaceuticals Co. said Thursday it established a strategic partnership with Abdi Ibrahim Pharmaceuticals to sell its Remicade biosimilar product in Turkey. Remicade is a globally renowned medication for rheuma...
Nutritional products most purchased Korean gifts
The most widely purchased Korean health food product came out to be nutritional products as gifts, such as vitamins and mineral-containing items, a poll conducted by a health food shopping mall said recently.
The A...
Multinational logistics firms up presence in Korea
Global logistics firms have expanded their presence in Korea by attracting more multinational drug companies operating here and individual customers.
Germany based Schenker Korea has concentrated their businesses ...
9th WSMI AP regional conference & 1st APSMI general assembly to kick off
The first Asia-Pacific Self-Medication Industry (APSMI) General Assembly and the ninth World Self-Medication Industry (WSMI) Asia-Pacific Regional Conference will be held from 18 to 20, October at COEX, southern Seoul...
Returned medicine haunts drug wholesalers
Recently, pharmaceutical wholesalers have found it still difficult to deal with returned medicines due to uncooperative stance of drug makers including multinational firms.
The Korea Pharmaceutical Wholesaler Assoc...
Can Crestor outpace Lipitor in sales?
Eyes are on the recent market trend that the sales of AstraZeneca’s Crestor (rosuvastatin) will overtake that of Pfizer’s Lipitor (atorvastatin), but the possibility is not large as the prices of Crestor 5 mg and 20 m...
Boehringer Ingelheim Korea severs ties with Daewoong
Boehringer Ingelheim Korea severed its strategic ties with Daewoong Pharmaceutical over the co-promotion of latter’s over-the-counter (OTC) medicines, it was learned yesterday.
Though the reasons for their sudden s...
Competition to be intensified in hepatitis B drug market
Competition in the domestic hepatitis B drug market is likely to heat up because Yuhan Corp., Korea’s exclusive seller of Gilead Science Viread, are poised to occupy the runner-up slot by deploying aggressive marketin...
Ethical sales dip 10% in August
After the government forced down prices of medicines in April, Korea's pharmaceutical industry is still feeling the pinch.
According to Ubist, the domestic ethical market for outpatients in August accounted for 691...
